NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Resilient Biotics

Resilient Biotics

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://resilientbiotics.com/

Last Round

Series A

Jan 29, 2021

Total Funding Raised

$7.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Resilient Biotics is a biotechnology company developing live biotherapeutics to combat complex respiratory infections in human and animal health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

live biotherapeuticsantibiotic alternativesmicrobiome therapeuticsanimal healthBovine Respiratory DiseaseBRDAgTechmicrobiome discovery platformbioinformaticslivestock healthanimal biotechPorcine Reproductive and Respiratory SyndromePRRSmachine learninggenomicsstrain discoverymulti-omics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resilient Biotics Comparables

Compare Resilient Biotics with similar companies based on industry and business-model similarity.

Resilient Biotics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BiomEdit
79%
General Probiotics
75%
Native Microbials
70%

Resilient Biotics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 29, 2021
AcceleratorFeb 9, 2017

Key People

Founding team and executive leadership

Rachelle Galvin

President And CEO

Executive Team

Resilient Biotics Investors

Notable investors and investment history

Resilient Biotics investors
InvestorRounds
Innovation In MotionSeries A
Fulcrum Global CapitalSeries A
Berkeley Catalyst FundSeries A
Viking Global InvestorsSeries A
ElancoSeries A
Illumina AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 62% MoM.

  • Jan 20, 2026

    Monthly visitors increased 863% MoM, reaching 867.

Resilient Biotics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Resilient Biotics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Resilient Biotics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range10
Year Founded2017
Last FundingJan 29, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.